The latest gynaecological cancer news
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…